neutralizing responses – Communicable Diseases Research

Artificial Cell Membrane Polymersome-Based Intranasal Beta Spike Formulation as a Second Generation Covid-19 Vaccine

Article

Published on 2022-10-252022-11-15
Journal: ACS Nano
[Category] COVID19(2023년), SARS, 변종, 비임상, 진단,

mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals

Article

Published on 2022-09-082022-11-15
Journal: Frontiers in Immunology
[Category] SARS, 변종, 진단, 치료기술,

[키워드] 95% CI ACE2 ACE2 Inhibition addition antibody Antibody responses Beta coronaviruses binding BNT162b2 vaccine Breakthrough infection characterized contribute cross-reactive Defense dose healthcare worker HKU1 human coronavirus humoral IgA IgA response IgG IgG level IgG response immunoassay individual individuals induce infected with SARS-CoV-2 investigated less Meso Scale Discovery mRNA mRNA vaccination mRNA vaccine mucosal mucosal immune mucosal immunity multiplex naïve neutralizing antibody neutralizing response neutralizing responses neutralizing responses. OC43 of BNT162b2 participant Participants pathogenic plasma positively correlated profile response SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2-specific IgG second dose selected sensitivity Spearman spike-specific IgG Transmission vaccination vaccine dose variants of concern
[DOI] 10.3389/fimmu.2022.953949 PMC 바로가기

Fourth BNT162b2 vaccination neutralization of omicron infection after heart transplantation

Article

Published on 2022-09-012022-11-15
Journal: The Journal of heart and lung transplantation : th
[Category] COVID19(2023년), SARS, 변종, 진단, 치료기술,

Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose

두 번째 백신 접종 후 180일 동안 의료 종사자(HW)에서 BNT162b 백신 2회 접종 후 세포 및 체액 면역 반응 및 돌발 감염

Article

Published on 2022-03-312022-09-12
Journal: Frontiers in Public Health
[Category] MERS, SARS, 진단,

[키워드] age all subject binding antibody BNT162b Breakthrough infection Cytopathic effect Day Delta VOC Dilution domain enrolled evaluated groups healthcare Healthcare workers highest Hospitalization human serum humoral Humoral response identify IFN-γ IgG IgG level IgG levels IgG titer Immunity individuals Infection information Live virus long-lasting maintain microneutralization mRNA vaccine mRNA vaccines mRNA vaccines. neutralized neutralizing antibody Neutralizing antibody titer neutralizing responses Neutralizing titer Older Predictive protective immunity Protein remained response SARS-CoV-2 second secretion shown stages subject subjects T-cell Response tested threshold Vaccine virus Volume was determined worker Wuhan strain
[DOI] 10.3389/fpubh.2022.847384 PMC 바로가기 [Article Type] Article

Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic

팬데믹 초기에 감염된 환자에서 SARS-CoV-2 Delta 변이체에 대한 중화 항체 반응의 동역학

Article

Published on 2022-02-282022-09-11
Journal: Journal of Korean medical science
[Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술,

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern

mRNA-1273 백신 유도 항체는 우려되는 SARS-CoV-2 변이체 전반에 걸쳐 Fc 효과기 기능을 유지합니다

Article

Published on 2022-02-082022-09-11
Journal: Immunity
[Category] COVID19(2023년), MERS, SARS, 변종, 진단,

[키워드] antibody approved binding both groups contribute convalescent convalescent individuals COVID-19 COVID-19 vaccine Efficacy exhibited Fc effector function function functional functional capacity functions humoral immune response in both groups independent independent of Interaction maintain Moderna mRNA mRNA vaccine mRNA-1273 mRNA-1273 vaccination neutralization Neutralizing neutralizing response neutralizing responses offer Protective Resilience response robust SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 variant SARS-CoV-2 variants the disease These data vaccine-induced antibodies vaccine-induced antibody Vaccines variant variants variants of concern variants of concern. VoC VOCs
[DOI] 10.1016/j.immuni.2022.01.001 PMC 바로가기 [Article Type] Article

Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection

임상 과정은 감염 후 1년이 지난 후에도 SARS-CoV-2 중화 항체의 초기 동역학, 크기 및 진폭에 영향을 미칩니다.

Article

Published on 2022-01-242022-09-11
Journal: Cell Reports Medicine
[Category] COVID19(2023년), MERS, SARS, 변종, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Alpha amplitude B cell B cell memory B cells Beta boost both groups clinical coronavirus coronavirus disease Coronavirus disease 2019 Course COVID-19 cross-neutralization activity determinant determinants Durability Efficacy evaluate expressing generate half-life Hospitalized humoral Humoral response identify immune responses Impact independent individual Infection long-term immune response long-term immune responses magnitude memory B cells mixed-effects models Multivariate analysis natural infection Neutralizing Neutralizing activity Neutralizing antibodies neutralizing responses participant Participants Patient plasma Primary infection prospective cohort pseudovirus pseudovirus pseudoviruses reduced respiratory response SARS-CoV-2 SARS-CoV-2 neutralizing antibody SARS-CoV-2 variant SARS-CoV-2 variants severe acute respiratory syndrome Coronavirus severity symptom onset vaccination variants variants of concern variants of concern.
[DOI] 10.1016/j.xcrm.2022.100523 PMC 바로가기 [Article Type] Article

Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines

Article

Published on 2022-01-042022-10-28
Journal: Vaccines
[Category] COVID-19,

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma

고도로 중화되는 COVID-19 회복기 혈장에서 SARS-CoV-2 탈출

420

Published on 2021-09-072022-09-10
Journal: Proceedings of the National Academy of Sciences of
[Category] SARS, 변종, 유전자 메커니즘, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody Antibody Response binding Brazil change computational modeling convalescent convalescent patient convalescent plasma convalescent sera coronavirus COVID-19 Deletion Donor E484K effective emerging variants evade Evolution generate immune immune evasion immune pressure immune response immune selective pressure Immunity Increases Infection insertion Japan monoclonal antibodies monoclonal antibody Mutation N-terminal domain neutralization neutralized Neutralizing Neutralizing antibodies neutralizing antibody neutralizing responses new virus NTD occurred passages plasma polyclonal predict Prevent RBD Receptor-binding domain respiratory SARS-CoV-2 serum Seven severe acute respiratory syndrome Coronavirus Significance similar changes South Africa susceptibility tested the receptor-binding domain United Kingdom vaccination Vaccine variant virus
[DOI] 10.1073/pnas.2103154118 PMC 바로가기 [Article Type] 420

The great escape? SARS-CoV-2 variants evading neutralizing responses

대단한 탈출? 중화 반응을 회피하는 SARS-CoV-2 변종

Article

Published on 2021-03-102022-09-11
Journal: Cell Host & Microbe
[Category] Fulltext, SARS, 변종, 진단,